KU Leuven Research  Development
Edit

KU Leuven Research Development

https://www.lrd.kuleuven.be
Last activity: 16.04.2026
Active
Invests in categories: DesignDevelopmentIndustryManagementMedTechProductResearchServiceSoftwareTechnology
KU Leuven Research & Development (LRD) is de dienst voor kennis- en technologietransfer (Technology Transfer Office - TTO) van de Associatie KU Leuven. Als technology transfer dienst ondersteunt LRD onderzoekers op vlak van intellectuele eigendomsrechten en onderzoekssamenwerking, en begeleidt hen bij de oprichting van spin-off bedrijven.
Portfolio
130
Mentions
8
Investment Type: Venture Capital

Portfolio 130

DateNameWebsiteTotal RaisedLocation
16.04.2026Photokretepkphotokrete.com--
16.04.2026Purtisopurtiso.com--
16.04.2026Belfort La...belfortlabs.com--
16.04.2026Hemastatxhemastatx.com--
16.04.2026Kure Cellskurecells.bio--
16.04.2026Gridualgridual.ai--
16.04.2026Circlaircirclair.com--
16.04.2026Landman.Bi...landman.bio--
16.04.2026EndLyz The...endlyz.com--
16.04.2026Gynaiagynaia.com--
Show more

Mentions in press and media 8

DateTitleDescription
04.02.2026Leuven-based AI running analysis platform Runeasi raises €1M for global growthRuneasi, a KU Leuven spin-off focused on running and movement analysis, has raised €1 million in a new investment round. The round was led by Smarter Ventures, with participation from existing investors Freshmen Fund, Gemma Frisius Fund, th...
13.01.2023FOx BIOSYSTEMS raises €5,8 million in a Series B-roundDiepenbeek, Belgium
24.11.2020With companies like Aphea Bio & Biotalys, Ghent is Europe’s hidden gem for ag biotechThe Belgian city of Ghent owes its medieval splendor to being in the middle of the sheep-filled pastureland of Flanders. In centuries past, this provided plentiful supplies of wool – just as breakthrough textiles technologies took off acros...
01.09.2020FOx Biosystems appoints Thomas van Elzakker as its new CEO Diepenbeek (Belgium), September 1st, 2020 – FOx Biosystems’ Board of Directors announces the appointment of Thomas van Elzakker as Chief Executive Officer per 1 September 2020. Van Elzakker takes over from company co-founder Filip Delport w...
20.02.2020Montis Biosciences launched with €8,4 million seed financing and a novel approach to immune-oncologyMontis was founded by Droia Ventures, VIB and KU Leuven based on the foundational science discovered by the labs of Peter Carmeliet (VIB-KU Leuven) and Massimiliano Mazzone (VIB-KU Leuven). For the seed financing, the founders were joined b...
26.06.2017Aphea.Bio Raises $10m in Series A and Grant Funding for Microbial Soil TechnologyBelgian startup Aphea.Bio has launched into the biopesticides and biostimulants sector with €9 million ($10.07m) in funding from a Series A funding round and a local R&D grant. The startup spun out of Vlaams Instituut voor Biotechnologi...
25.10.2013Trod Medical Completes €4.75M Series B FinancingTrod Medical NV/SA, a Leuven, Belgium-based medical device company, completed a €4.75m Series B financing. The round was co-led by Vesalius Biocapital (through its Vesalius Biocapital II Arkiv N.V. Fund) and Capricorn Venture Partners (thro...
06.10.2011Cartagenia Raises €2.2M in FundingCartagenia, a Leuven, Belgium-based provider of knowledge, software and services for efficient patient genetics, has raised €2.2m in funding. Investors include existing shareholders PMV/VINNOF and Gemma Frisius Fund and the founders, which ...

Reviews 0

Sign up to leave a review

Sign up Log In